The five tools that show up in nearly every high-pass USMLE Step 1 study plan in 2026 are UWorld (the QBank standard), AMBOSS (AI-tutored reference plus QBank), Anki with the AnKing deck (spaced repetition), SketchyMedical (visual mnemonics), and Pathoma (preclinical pathology). Step 1 has been pass/fail since January 2022, but the content load has not shrunk and Step 2 CK scores increasingly determine residency competitiveness. AI features have shifted what a study plan looks like, but not which tools sit at its center.
This guide covers the tool stack. For tactical scheduling and dedicated-period planning, the NBME's own preparation resources and Reddit's r/medicalschool wiki remain the most current source.
What does the modern USMLE Step 1 study stack look like?
The Association of American Medical Colleges (AAMC) 2025 student survey reported that 96% of US medical students used UWorld, 78% used Anki, 64% used Pathoma, and 58% used SketchyMedical during their preclinical years. AMBOSS adoption climbed past 41% in the same survey, driven by AI tutoring features that were absent at the previous edition. None of these tools is technically required; collectively they cover question practice, spaced repetition, video review, and visual mnemonics in a way that maps to the NBME content outline.
AI has entered each tool differently. AMBOSS layered an AI study coach over its QBank. UWorld added AI-generated explanations and adaptive recommendations. AnKing now includes optional AI tag suggestions. SketchyMedical added AI-driven question generation tied to its videos. Pathoma remains the least AI-modified, but its core video product is still rated highest for pathology coverage.
UWorld: the QBank standard
UWorld is the de facto QBank for USMLE Step 1, with ~3,800 questions, detailed explanations, and tightly written illustrations. Pricing for Step 1 alone ranges from $319 for a 1-month subscription to $560 for 12 months. NBME-aligned question writing and explanation depth remain the reason most students treat UWorld as non-negotiable. AAMC survey data shows 96% usage among US allopathic students preparing for Step 1.
The 2026 AI updates added explanation-generation in plain language for difficult concepts and adaptive question recommendations based on weakness patterns. The core value, the question quality and explanation depth, has not changed. See the full UWorld profile.
AMBOSS: the AI-tutored reference and QBank
AMBOSS combines a clinical reference (think First Aid plus UpToDate, in scope) with a QBank and an AI tutor. Pricing runs $15-30 per month for students and is often cheaper through institutional licenses. The AI tutor explains concepts conversationally, generates practice questions on weak topics, and integrates with Anki via a one-click extension that pulls AMBOSS-cited explanations into your card flow. Adoption climbed 18 percentage points in the AAMC 2025 survey relative to 2023, the largest jump of any tool tracked.
AMBOSS does not replace UWorld for high-scorers. It complements it. Students typically use AMBOSS during preclinical for reference and concept-building, then run UWorld during dedicated for QBank exposure. See the full AMBOSS profile.
Anki and AnKing: spaced repetition that actually sticks
Anki is free, open-source, and the substrate for community-built decks. The AnKing deck is the consensus USMLE flashcard collection with over 30,000 cards covering Step 1 and Step 2 CK content. AnkiHub ($5-10 per month) provides collaborative updates, so the deck improves as the community refines tagging and content. Anki is the highest-leverage time investment for most students if started early in M1, lower-leverage when started in dedicated. The AAMC 2025 survey reported 78% adoption among M1-M2 students.
Three rules from r/medicalschool consensus on Anki usage. First, do reviews every day; the system breaks if you skip. Second, unsuspend cards as you cover topics; never start with all 30,000. Third, use AnKing as the base deck rather than building your own from scratch; community-vetted cards outperform self-built cards for board content. See the full Anki AnKing profile.
SketchyMedical and Pathoma: the visual core
SketchyMedical covers microbiology, pharmacology, and pathology through visual mnemonic videos. Pricing runs around $349-$599 depending on bundle and length. The 2026 AI update added on-demand question generation tied to specific sketches and adaptive flagging of weak topics. AAMC 2025 adoption: 58%. Reddit consensus is that Sketchy is highest-leverage for microbiology and pharmacology, less essential for pathology where Pathoma dominates.
Pathoma (Husain Sattar's pathology videos plus textbook) costs $85 for a 3-month subscription or $100 for 12 months. It remains near-universal in US preclinical years (64% AAMC 2025 adoption) and the rare tool that has not been disrupted by AI. The video lectures, paired with the textbook, deliver pathology content faster than any alternative. See the full Pathoma profile.
What does a realistic 2026 study plan look like?
The most common high-pass pattern compiled from r/medicalschool 2025-2026 study threads:
M1: Anki (AnKing) daily, AMBOSS for reference, Sketchy for micro/pharm as those courses come up.
M2: Pathoma during pathology coursework, continued Anki, AMBOSS for clinical correlation.
Dedicated (6-8 weeks pre-Step 1): UWorld primary, NBME self-assessments weekly, Pathoma video re-watch, Sketchy quick review, Anki maintenance only.
The plan is intentionally lean. Adding more tools rarely raises scores; ruthlessly using fewer tools well consistently does. For the broader tool universe (CME, anatomy, clinical-skills tools), see our best AI medical education tools guide.
Frequently asked questions
Is UWorld still worth $560 if Step 1 is pass/fail?
Yes. UWorld for Step 1 also serves as preparation for Step 2 CK, where scoring still matters. Many students extend the same subscription to Step 2 prep, which improves the per-month math. The QBank is also a learning tool, not just a test predictor; explanation depth is what makes it worth the price.
Can ChatGPT or Claude replace any of these tools?
Not yet. General LLMs hallucinate medical content frequently enough that they are unsafe as a primary study tool. They are useful as concept-explainers once you already know the topic and can detect errors, or as drilling partners for differential diagnosis when paired with verified resources. AMBOSS's AI tutor is the better choice because it's grounded in the AMBOSS reference content.
What about Boards & Beyond or OnlineMedEd?
Both are excellent video resources. Boards & Beyond is the most common preclinical video alternative to AMBOSS for concept-building; OnlineMedEd shifts toward Step 2 CK and clinical-rotation content. Adding either to the core stack is reasonable; both also feature in our education guide.
How early should I start dedicated UWorld?
Most US students start UWorld 6-8 weeks before Step 1. Earlier exposure is reasonable in tutor mode during M2, but heavy QBank practice before content mastery wastes the questions. The NBME self-assessments are the right benchmark; aim for pass-equivalent on two consecutive self-assessments before testing.